These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 1757944

  • 1. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
    Silverman ED, Laxer RM, Nelson DL, Rubin LA.
    J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
    [Abstract] [Full Text] [Related]

  • 2. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis.
    Madson KL, Moore TL, Lawrence JM, Osborn TG.
    J Rheumatol; 1994 Dec; 21(12):2359-63. PubMed ID: 7699643
    [Abstract] [Full Text] [Related]

  • 3. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
    Muzaffer MA, Dayer JM, Feldman BM, Pruzanski W, Roux-Lombard P, Schneider R, Laxer RM, Silverman ED.
    J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA, Dooley MA, Dawson DV, Pisetsky DS, Polisson RP.
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A multicenter study to evaluate a novel assay for quantitation of soluble interleukin 2 receptor in renal transplant recipients.
    Schroeder TJ, Helling T, McKenna RM, Rush D, Jeffrey JR, Brewer B, Martin LA, Traylor D, Fisher RA, First MR.
    Transplantation; 1992 Jan; 53(1):34-40. PubMed ID: 1733082
    [Abstract] [Full Text] [Related]

  • 7. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
    De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A.
    J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity.
    Rubin LA, Snow KM, Kurman CC, Nelson DL, Keystone EC.
    J Rheumatol; 1990 May; 17(5):597-602. PubMed ID: 2359067
    [Abstract] [Full Text] [Related]

  • 10. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
    Setoyama Y, Imai J, Ishikawa T, Sakaida H, Takaori-Kondo A, Kawamata S, Uchiyama T.
    Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
    [Abstract] [Full Text] [Related]

  • 11. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G, Shohat B, Bshara J, Wysenbeek A, Weinberger A.
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [Abstract] [Full Text] [Related]

  • 12. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V.
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [Abstract] [Full Text] [Related]

  • 13. [Evaluation of interleukin-2 soluble receptor in patients with trypanosomiasis americana in Panama].
    Pascale JM, Sosa CE, Orn A.
    Rev Med Panama; 1991 Sep; 16(3):184-8. PubMed ID: 1767036
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S, Imanaka H, Maeno N, Shigemori M, Masuda K, Hokonohara M, Miyata K.
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH, Ciardelli T, Wu Z, Langholz E, Kirman I.
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [Abstract] [Full Text] [Related]

  • 19. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
    Lipnick RN, Sfikakis PP, Klipple GL, Tsokos GC.
    Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
    [Abstract] [Full Text] [Related]

  • 20. [Soluble IL-2 receptor levels in rheumatic diseases].
    Takaya M, Ichikawa Y, Shimizu H, Uchiyama M, Moriuchi J, Arimori S.
    Ryumachi; 1993 Jun; 33(3):229-34. PubMed ID: 8346465
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.